|
1
|
Puche JE, Saiman Y and Friedman SL:
Hepatic stellate cells and liver fibrosis. Compr Physiol.
3:1473–1492. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brenner DA, Waterboer T, Choi SK,
Lindquist JN, Stefanovic B, Burchardt E, Yamauchi M, Gillan A and
Rippe RA: New aspects of hepatic fibrosis. J Hepatol. (32)(Suppl):
32–38. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Moreira RK: Hepatic stellate cells and
liver fibrosis. Arch Pathol Lab Med. 131:1728–1734. 2007.PubMed/NCBI
|
|
4
|
Lim YS and Kim WR: The global impact of
hepatic fibrosis and end-stage liver disease. Clin Liver Dis.
12:733–746. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Richburg JH, Myers JL and Bratton SB: The
role of E3 ligases in the ubiquitin-dependent regulation of
spermatogenesis. Semin Cell Dev Biol. 30:27–35. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nagano Y, Mavrakis KJ, Lee KL, Fujii T,
Koinuma D, Sase H, Yuki K, Isogaya K, Saitoh M, Imamura T, et al:
Arkadia induces degradation of SnoN and c-Ski to enhance
transforming growth factor-beta signaling. J Biol Chem.
282:20492–20501. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mavrakis KJ, Andrew RL, Lee KL,
Petropoulou C, Dixon JE, Navaratnam N, Norris DP and Episkopou V:
Arkadia enhances Nodal/TGF-beta signaling by coupling
phospho-Smad2/3 activity and turnover. PLoS Biol. 5:e672007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ling H, Roux E, Hempel D, Tao J, Smith M,
Lonning S, Zuk A, Arbeeny C and Ledbetter S: Transforming growth
factor β neutralization ameliorates pre-existing hepatic fibrosis
and reduces cholangiocarcinoma in thioacetamide-treated rats. PLoS
One. 8:e544992013. View Article : Google Scholar
|
|
9
|
Massagué J and Wotton D: Transcriptional
control by the TGF-beta/Smad signaling system. EMBO J.
19:1745–1754. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu F, Liu C, Zhou D and Zhang L:
TGF-β/SMAD pathway and its regulation in hepatic fibrosis. J
Histochem Cytochem. 64:157–167. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Koinuma D, Shinozaki M, Komuro A, Goto K,
Saitoh M, Hanyu A, Ebina M, Nukiwa T, Miyazawa K, Imamura and
Miyazono K: Arkadia amplifies TGF-beta superfamily signalling
through degradation of Smad7. EMBO J. 22:6458–6470. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Levy L, Howell M, Das D, Harkin S,
Episkopou V and Hill CS: Arkadia activates Smad3/Smad4-dependent
transcription by triggering signal-induced SnoN degradation. Mol
Cell Biol. 27:6068–6083. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Le Scolan E, Zhu Q, Wang L, Bandyopadhyay
A, Javelaud D, Mauviel A, Sun L and Luo K: Transforming growth
factor-beta suppresses the ability of Ski to inhibit tumor
metastasis by inducing its degradation. Cancer Res. 68:3277–3285.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tsubakihara Y, Hikita A, Yamamoto S,
Matsushita S, Matsushita N, Oshima Y, Miyazawa K and Imamura T:
Arkadia enhances BMP signalling through ubiquitylation and
degradation of Smad6. J Biochem. 158:61–71. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Aghaei I, Shabani M, Doustar N, Nazeri M
and Dehpour A: Peroxisome proliferator-activated receptor-γ
activation attenuates motor and cognition impairments induced by
bile duct ligation in a rat model of hepatic cirrhosis. Pharmacol
Biochem Behav. 120:133–139. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Javadi-Paydar M, Ghiassy B, Ebadian S,
Rahimi N, Norouzi A and Dehpour AR: Nitric oxide mediates the
beneficial effect of chronic naltrexone on cholestasis-induced
memory impairment in male rats. Behav Pharmacol. 24:195–206. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Uchinami H, Seki E, Brenner DA and
D’Armiento J: Loss of MMP 13 attenuates murine hepatic injury and
fibrosis during cholestasis. Hepatology. 44:420–429. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Greenbaum D, Colangelo C, Williams K and
Gerstein M: Comparing protein abundance and mRNA expression levels
on a genomic scale. Genome Biol. 4:1172003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Khositseth S, Pisitkun T, Slentz DH, Wang
G, Hoffert JD, Knepper MA and Yu MJ: Quantitative protein and mRNA
profiling shows selective post-transcriptional control of protein
expression by vasopressin in kidney cells. Mol Cell Proteomics.
10:M110.0040362011. View Article : Google Scholar :
|
|
21
|
Lian Z, Kluger Y, Greenbaum DS, Tuck D,
Gerstein M, Berliner N, Weissman SM and Newburger PE: Genomic and
proteomic analysis of the myeloid differentiation program: Global
analysis of gene expression during induced differentiation in the
MPRO cell line. Blood. 100:3209–3220. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gerner C, Vejda S, Gelbmann D, Bayer E,
Gotzmann J, Schulte-Hermann R and Mikulits W: Concomitant
determination of absolute values of cellular protein amounts,
synthesis rates, and turnover rates by quantitative proteome
profiling. Mol Cell Proteomics. 1:528–537. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu FY, Li XZ, Peng YM, Liu H and Liu YH:
Arkadia regulates TGF-beta signaling during renal tubular
epithelial to mesenchymal cell transition. Kidney Int. 73:588–594.
2008. View Article : Google Scholar
|
